ABOUT

 

With its foam delivery system, EVOCLIN® (clindamycin phosphate) Foam, 1% provides easy, spreadable coverage of hair-bearing and hairless body parts, with minimal residue. The foam dissipates quickly, does not drip, is nonstaining, nonbleaching, and fragrance free.

EVOCLIN Foam is indicated for topical application in the treatment of acne vulgaris in patients 12 years and older. It is for topical use only and not for oral, ophthalmic, or intravaginal use. Avoid contact with eyes, mouth, lips, other mucous membranes, or areas of broken skin. If contact occurs, rinse thoroughly with water. In view of the potential for diarrhea, bloody diarrhea, and pseudomembranous colitis, the physician should consider whether other agents are more appropriate.

The foam is applied once daily to affected areas after the skin is washed with mild soap and allowed to fully dry. The entire affected area should be covered with foam. If there has been no improvement after 6 to 8 weeks or if the condition becomes worse, treatment should be discontinued.

 


IMPORTANT SAFETY INFORMATION


Full Prescribing Information


  • EVOCLIN® (clindamycin phosphate) Foam, 1% is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, or a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis, including pseudomembranous colitis.

  • Prescribe with caution in atopic individuals.

  • Concomitant topical acne therapy should be used with caution since a possible cumulative irritancy may occur, especially with the use of peeling, desquamating, or abrasive agents. If irritation or dermatitis occurs, EVOCLIN Foam should be discontinued.

  • Diarrhea, bloody diarrhea, and pseudomembranous colitis have been reported with systemic and rarely with topical clindamycin. Discontinuation is recommended if significant diarrhea develops.

  • In clinical trials, the most common adverse events were headache (3%) and application-site reactions, including burning (6%), itching (1%), and dryness (1%).

  • The contents of EVOCLIN Foam are flammable; patients should avoid fire, flame, and/or smoking during and immediately following application.








EVOCLIN Foam is indicated for topical application in the treatment of acne vulgaris in patients 12 years and older.